Markets & Regulations

Japan’s PuRec to supply mesenchymal stem cells

Japan’s PuRec to supply mesenchymal stem cells

By Wang Fangqing

Regenerative medicine developers now have a new supplier for mesenchymal stem cells (MSCs), the multipotent stromal cells derived from marrow and other tissues like muscle and dental pulp for tissue repair.

Althea announces first phase of ADC offerings

Althea announces first phase of ADC offerings

By Melissa Fassbender

Althea is expanding its biological drug product manufacturing operations to include highly active materials, such as Antibody Drug Conjugates (ADCs).